Anavex Life Sciences
AVXL
#9983
Rank
โ‚ฌ68.82 M
Marketcap
0,74ย โ‚ฌ
Share price
-12.42%
Change (1 day)
-75.91%
Change (1 year)

EPS for Anavex Life Sciences (AVXL)

EPS in 2026 (TTM): -0,13ย โ‚ฌ

According to Anavex Life Sciences 's latest financial reports the company's current EPS (TTM) is -0,14ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -0,42ย โ‚ฌ.

EPS history for Anavex Life Sciences from 2025 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-0,13ย โ‚ฌ-69.7%
2025-0,42ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Ligand Pharmaceuticals
LGND
2,35ย โ‚ฌ-1,826.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Corcept Therapeutics
CORT
1,36ย โ‚ฌ-1,100.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Palatin Technologies
PTN
-6,86ย โ‚ฌ 4,933.33%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-1,23ย โ‚ฌ 800.00%๐Ÿ‡บ๐Ÿ‡ธ USA